Please assess the completion status of the following clinical trial:

Trial Title: Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients \> 18 years of age~* OAB symptoms for \> 3 months~* Symptoms defined as greater than 3 episodes/week of an uncontrolled urge to void causing incontinence.~* May or may not be accompanied by urinary frequency~* May be accompanied by stress urinary incontinence where stress incontinence does not predominate~Exclusion Criteria:~* Male Patients~* Underlying cortical or spinal cord pathology including SCI, MS, or~* Parkinson's Disease~* Urinary retention with post-void residual \> 150cc~* Current treatment or treatment within the last 3 months with anticholinergic medications~* Patients not able to complete the questionaires or voiding diaries in English~* Pregnancy~* Active urinary tract infections~* Bladder Cancer or unevaluated hematuria~* Known diagnosis of narrow angle glaucoma~* Severe constipation~* History of reduced renal function (CrCl\<30ml/min)~* History of liver disease~* Current treatment with cytochrome P450 inhibitor medications

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Vesicare (Type: ACTIVE_COMPARATOR): Vesicare alone
- Vesicare/behavioral modification (Type: ACTIVE_COMPARATOR): Vesicare plus behavioral modification

Based on this trial design, predict the completion outcome and termination type (if applicable).